Chronic Inflammatory Demyelinating Polyneuropathy Diagnosis
CIDP diagnosis is based on a clinical syndrome of progressive or relapsing weakness and sensory symptoms plus laboratory and supportive testing. Standardized diagnostic criteria incorporate electrophysiology and imaging findings and emphasize exclusion of key alternative diagnoses. [1]
Clinical Syndrome Pattern
CIDP is diagnosed in the setting of a progressive motor and sensory neuropathy course that is chronic and immune-mediated in nature. [1]
Electrodiagnostic Confirmation
Electrophysiological testing is used to support CIDP diagnosis using demyelinating-pattern evidence. [1]
Cerebrospinal Fluid and Other Supportive Tests
Cerebrospinal fluid (CSF) analysis is used as a supportive diagnostic test, with elevated CSF protein described as a factor associated with diagnostic support and therapeutic response in patients considered “possible CIDP” by clinical presentation but not meeting key electrodiagnostic criteria. [2]
Imaging Support
Imaging of the peripheral nervous system is used as a supportive diagnostic test. Plexus magnetic resonance imaging (MRI) is described among diagnostic tests evaluated in patients with possible CIDP in whom core electrodiagnostic criteria were not met. [2]
Differentiation From Mimics
Key differential diagnoses are addressed directly within CIDP diagnostic recommendations to enhance diagnostic accuracy. [1]
Diagnostic Uncertainty and Misdiagnosis Rates
Initial misdiagnosis occurs in a substantial minority of patients, with 37.2% reported as the proportion with initial misdiagnosis in a multinational real-world survey. [3]
Escalation to Nerve Biopsy When Needed
Nerve biopsy is used selectively when confirmation is required and when the diagnosis remains uncertain despite electrophysiology and other supportive testing. [1]
Practical Diagnostic Test Set Used in “Possible CIDP” Workups
In patients with clinical presentations suggesting CIDP but lacking criteria on electrodiagnostic testing, the evaluated supportive test set includes CSF analysis, somatosensory evoked potentials (SSEPs), and plexus MRI. [2]